Scientific Advisory Board

Carmela R. Abraham, PhD

Boston University School of Medicine, Boston, Massachusetts

Professor of Biochemistry, Pharmacology and Experimental Therapeutics at Boston University School of Medicine, Boston, Massachusetts

Founder and Scientific Advisor, Klogene Therapeutics, Boston, Massachusetts

  • Senior Editor “American Journal of Neurodegenerative Disease”
  • Associate Editor “Journal of Alzheimer’s Disease”
Kaj Blennow, MD, PhD

Sahlgrenska University Hospital, Gothenburg, Sweden

Professor of Clinical Neurochemistry, University of Gothenburg, Sweden

Head of Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Former researcher at the Medical Research Council (MRC), Sweden
Keith Crutcher, PhD

University of Cincinnati, Cincinnati, Ohio

Volunteer Professor, Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio

  • Past Professor and Director of Research, Department of Neurosurgery, University of Cincinnati
  • Former Scientific Review Officer, Emerging Technologies & Training in Neuroscience, Center for Scientific Review, NIH
Murali Doraiswamy, MBBS, FRCP

Duke University School of Medicine, Durham, North Carolina

Professor of Psychiatry and Medicine (Geriatrics), Duke University School of Medicine, Durham, North Carolina

Director of the Neurocognitive Disorders, Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina

  • Member, Duke Institute for Brain Sciences
  • Member, Duke Center for Applied Genomics and Precision Medicine
  • Co-author, “The Alzheimer’s Action Plan”